Home › Bronchiolitis Obliterans Syndrome
Bronchiolitis Obliterans Syndrome clinical trials recruiting in the U.S.
41 studies for Bronchiolitis Obliterans Syndrome are recruiting participants at sites across the United States.
Cities with the most studies
- Boston, MA12 studies
- Seattle, WA11 studies
- Atlanta, GA9 studies
- New York City, NY9 studies
- Houston, TX8 studies
- Baldwin Park, CA7 studies
- Los Angeles, CA7 studies
- Miami, FL7 studies
- Durham, NC6 studies
- Chicago, IL6 studies
- Philadelphia, PA6 studies
- Tampa, FL6 studies
- Washington, DC6 studies
- Detroit, MI5 studies
- Columbus, OH5 studies
- Portland, OR5 studies
- San Francisco, CA5 studies
- Pittsburgh, PA5 studies
- Nashville, TN4 studies
- Austin, TX4 studies
- Charlotte, NC4 studies
- Orlando, FL4 studies
- Salt Lake City, UT4 studies
- Denver, CO4 studies
- San Antonio, TX4 studies
- Richmond, VA4 studies
- St. Louis, MO4 studies
- Ann Arbor, MI4 studies
- Edison, NJ3 studies
- Birmingham, AL3 studies
- Dallas, TX3 studies
- Kansas City, KS3 studies
- Charleston, SC3 studies
- Mountain View, CA3 studies
- Cleveland, OH3 studies
- Cincinnati, OH3 studies
By state
- Alabama3 studies
- Arizona3 studies
- California16 studies
- Colorado4 studies
- District of Columbia3 studies
- Florida14 studies
- Georgia10 studies
- Illinois7 studies
- Kansas5 studies
- Maryland5 studies
- Massachusetts13 studies
- Michigan7 studies
- Missouri4 studies
- New Jersey4 studies
- New York11 studies
- North Carolina7 studies
- Ohio8 studies
- Oregon5 studies
- Pennsylvania11 studies
- South Carolina3 studies
- Tennessee6 studies
- Texas12 studies
- Utah4 studies
- Virginia4 studies
- Washington11 studies
Recently updated studies
A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
RecruitingPhase 2
Ages 2 to 17 · All sexes · Updated Nov 13, 2026 · NCT07124078A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 13, 2026 · NCT06585774Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
RecruitingPhase 2
Ages 1 to 18 · All sexes · Updated Nov 10, 2026 · NCT07354074Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
RecruitingPhase 1/2Healthy volunteers welcome
Ages 12 to 120 · All sexes · Updated Nov 9, 2026 · NCT05327023Evaluation of Patients With Immune Function Abnormalities
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Nov 9, 2026 · NCT00128973Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
RecruitingPhase 1/2Healthy volunteers welcome
Ages 12 to 85 · All sexes · Updated Nov 9, 2026 · NCT04959175Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD
RecruitingPhase 1
Ages 2 and older · All sexes · Updated Nov 4, 2026 · NCT06991361Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT06434363Uncovering the Mechanism of Pain Relief by Peripheral Transcutaneous Magnetic Stimulation
Recruiting
Ages 19 to 80 · All sexes · Updated Oct 27, 2026 · NCT07199361A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT06615050Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease
Recruiting
Ages 18 and older · All sexes · Updated Oct 21, 2026 · NCT07535008Mindfulness Intervention to Reduce Patient Reported Symptoms in Patients With Chronic Graft-Versus-Host Disease
Recruiting
Ages 18 and older · All sexes · Updated Oct 16, 2026 · NCT07733141Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 6, 2026 · NCT05919511Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07011810A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
RecruitingPhase 2
Ages 1 to 18 · All sexes · Updated Sep 22, 2026 · NCT07116031An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
RecruitingPhase 3
Ages 10 to 65 · All sexes · Updated Sep 21, 2026 · NCT07395232Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT05996627Repetitive Transcranial Magnetic Stimulation, a Form of Non-invasive Brain Stimulation, as a Possible Treatment for Post-stroke Fatigue
RecruitingPhase 2
Ages 34 to 80 · All sexes · Updated Sep 14, 2026 · NCT05584124Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions
RecruitingHealthy volunteers welcome
Ages 12 and older · All sexes · Updated Sep 3, 2026 · NCT02592291Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHD
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT07127926Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT06660355NAVIGATE Kidney: A Multi-level Intervention to Reduce Kidney Health Disparities
Recruiting
Ages 18 to 75 · All sexes · Updated Jul 24, 2026 · NCT06810622UTSW NORC Pilot Spinal Cord Injury Dietary Program
Recruiting
Ages 18 to 65 · All sexes · Updated Jul 15, 2026 · NCT06924177Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury
RecruitingPhase 2
Ages 18 to 55 · All sexes · Updated Jul 15, 2026 · NCT05951777Plasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLAD
RecruitingObservational study
Ages 7 and older · All sexes · Updated Jul 14, 2026 · NCT07434869From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.